Top

Published in:

01-04-2012 | Preclinical study

The anatomy of fluid-yielding ducts in breast cancer

Authors: Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Ann Ward, Clare M. Isacke, Gerald P. H. Gui

Published in: Breast Cancer Research and Treatment | Issue 2/2012

Abstract

The concept of an intraductal approach to evaluate the breast microenvironment assumes direct access to the cancer-containing duct. Central duct access to the cancer-affected lobe is essential if cytology or cell markers are to be useful indicators of pre-malignant change. Access to the cancer-bearing lobe would be less important if field change effects of malignant change were predominantly supra-lobar. The aim of this study was to determine how often duct lavage fluid drains the breast cancer-affected segment. 58 patients undergoing mastectomy for breast cancer were recruited among which 47 had at least one fluid-yielding duct. Following duct lavage, fluid-yielding ducts were perfused ex vivo with Polyurethane Elastomer (PU4ii) resin. Specimens were sliced sagittally, and the extent of resin perfusion and anatomical relationship to the cancer-affected segment was recorded. Computed tomography (CT) scanning was performed on selected mastectomies before cut-up for a feasibility study of 3D duct reconstruction. The median number of fluid-yielding ducts cannulated per cancer-affected breast was 2 (range 1–4). 35/47 (74%) mastectomy specimens were successfully cannulated for resin perfusion. 29/35 (83%) showed tracing of the cancer-affected duct system, 6/35 resin perfusions traced duct systems unaffected by cancer and 12/35 perfusions extravasated. The proportion of sagittal breast slices perfused by resin was 13–68% (median 43%). Volume rendering CT showed it is feasible to produce a simulated image of the perfused ducts. Duct access to the cancer-containing segment is feasible in the majority of patients. Fluid-yielding ducts proportionately drain a significant volume of the breast. Large symptomatic cancers may cause obstruction with distal collapse. Further quantitative study of breast perfusion CT scans may be helpful for estimating the volume fraction of breast tissue perfused by fluid-yielding ducts. The intraductal approach is a valid concept for biomarker assessment of cancer-containing breast segments.

Dua RS, Isacke CM, Gui GP (2006) The intraductal approach to breast cancer biomarker discovery. J Clin Oncol 24:1209–1216PubMedCrossRef

Sauter ER, Shan S, Hewett JE, Speckman P, Du Bois GC (2005) Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer 114:791–796PubMedCrossRef

Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM (2006) Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68PubMedCrossRef

Misek DE, Kuick R, Wang H, Galchev V, Deng B, Zhao R et al (2005) A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 5:3343–3352PubMedCrossRef

Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T et al (2006) Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 1(12):3306–3310CrossRef

Fackler MJ, Rivers A, Teo WW, Mangat A, Taylor E, Zhang Z et al (2009) Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res 15:3802–3811PubMedCrossRef

Zhu W, Qin W, Hewett JE, Sauter ER (2010) Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. Int J Cancer 126:474–482PubMedCrossRef

Dooley WC (2009) Breast ductoscopy and the evolution of the intra-ductal approach to breast cancer. Breast J 15(1):S90–S94PubMedCrossRef

Matsunaga T, Misaka T, Hosokawa K, Taira S, Kim K, Serizawa H et al (2009) Intraductal approach to the detection of intraductal lesions of the breast. Breast Cancer Res Treat 118:9–13PubMedCrossRef

10.

Ling H, Liu GY, Lu JS, Love S, Zhang JX, Xu XL et al (2009) Fiberoptic ductoscopy-guided intraductal biopsy improves the diagnosis of nipple discharge. Breast J 15(2):168–175PubMedCrossRef

11.

Going JJ, Mohun TJ (2006) Human breast duct anatomy, the ‘sick lobe’ hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat 97(3):285–291PubMedCrossRef

12.

Rusby JE, Brachtel EF, Michaelson JS, Koerner FC, Smith BL (2007) Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications. Breast Cancer Res Treat 106(2):171–179PubMedCrossRef

13.

Start RD, Layton CM, Cross SS, Smith JHF (1992) Reassessment of the rate of fixative diffusion. J Clin Pathol 45:1120–1121PubMedCrossRef

14.

Khan SA, Wiley EL, Rodriguez N, Baird C, Ramakrishnan R, Nayar R et al (2004) Ductal lavage findings in women with known breast cancer undergoing mastectomy. J Natl Cancer Inst 96:1510–1517PubMedCrossRef

15.

Brogi E, Robson M, Panageas KS, Casadio C, Ljung BM, Montgomery L (2003) Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study. Cancer 98:2170–2176PubMedCrossRef

16.

Krucker T, Lang A, Meyer EP (2006) New polyurethane-based material for vascular corrosion casting with improved physical and imaging characteristics. Microsc Res Tech 69:138–147PubMedCrossRef

17.

Mannino M, Yarnold J (2009) Effect of breast-duct anatomy and wound-healing responses on local tumour recurrence after primary surgery for early breast cancer. Lancet Oncol 10:425–429PubMedCrossRef

18.

Turnbull LW, Brown SR, Olivier C, Harvey I, Brown J, Drew P et al (2010) Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 14:1–182PubMed

Title: The anatomy of fluid-yielding ducts in breast cancer
Authors: Dominique Twelves
Ashutosh Nerurkar
Peter Osin
Ann Ward
Clare M. Isacke
Gerald P. H. Gui
Publication date: 01-04-2012
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-011-1623-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer

Surgical treatment of early stage breast cancer in elderly: an international comparison

Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors

Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways

Keynote webinar | Spotlight on antibody–drug conjugates in cancer